Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.6B | 1.5B | 1.6B | 1.7B |
Cost of revenue | 1.3B | 1.2B | 1.2B | 1.3B |
Gross profit | 322M | 305M | 349M | 364M |
Operating expense | ||||
Research & development | 29M | 22M | 27M | 27M |
Selling general and admin | 290M | 275M | 289M | 293M |
Other operating expenses | 42M | -36M | 34M | 33M |
Operating income | -23M | 55M | 24M | 28M |
Non operating interest income | ||||
Income | 2M | 2M | 1M | 1M |
Expense | 12M | 40M | 13M | 12M |
Other income expense | — | — | — | — |
Pretax income | -61M | -68M | 2M | -12M |
Tax provision | -4M | -4M | 0 | 4M |
Net income | -57M | -64M | 2M | -16M |
Basic EPS | -0.7 | — | 0.0 | -0.2 |
Diluted EPS | -0.7 | — | 0.0 | -0.2 |
Basic average shares | 86.3M | — | 86.3M | 86.3M |
Diluted average shares | 86.3M | — | 86.3M | 86.3M |
EBITDA | 86M | 118M | 154M | 141M |
Net income from continuing op. | -61M | -68M | 2M | -12M |
Minority interests | 0 | 0 | -1M | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |